These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 1804011

  • 1. Isepamicin disposition in subjects with various degrees of renal function.
    Halstenson CE, Kelloway JS, Affrime MB, Lin CC, Teal MA, Shapiro BE, Awni WM.
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2382-7. PubMed ID: 1804011
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of ampicillin (2.0 grams) and sulbactam (1.0 gram) coadministered to subjects with normal and abnormal renal function and with end-stage renal disease on hemodialysis.
    Blum RA, Kohli RK, Harrison NJ, Schentag JJ.
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1470-6. PubMed ID: 2817847
    [Abstract] [Full Text] [Related]

  • 3. Disposition of guanadrel in subjects with normal and impaired renal function.
    Halstenson CE, Opsahl JA, Abraham PA, Schwenk MH, Andreadis NA, Antal EJ, Matzke GR.
    J Clin Pharmacol; 1989 Feb; 29(2):128-32. PubMed ID: 2715368
    [Abstract] [Full Text] [Related]

  • 4. Disposition of cefpodoxime proxetil in healthy volunteers and patients with impaired renal function.
    St Peter JV, Borin MT, Hughes GS, Kelloway JS, Shapiro BE, Halstenson CE.
    Antimicrob Agents Chemother; 1992 Jan; 36(1):126-31. PubMed ID: 1590677
    [Abstract] [Full Text] [Related]

  • 5. Famotidine disposition in children and adolescents with chronic renal insufficiency.
    Maples HD, James LP, Stowe CD, Jones DP, Hak EB, Blumer JL, Vogt B, Wilson JT, Kearns GL, Wells TG, Network of Pediatric Pharmacology Research Units.
    J Clin Pharmacol; 2003 Jan; 43(1):7-14. PubMed ID: 12520622
    [Abstract] [Full Text] [Related]

  • 6. Disposition of famotidine in renal insufficiency.
    Halstenson CE, Abraham PA, Opsahl JA, Chremos AN, Keane WF, Matzke GR.
    J Clin Pharmacol; 1987 Oct; 27(10):782-7. PubMed ID: 3429684
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of lomefloxacin in renally compromised patients.
    Blum RA, Schultz RW, Schentag JJ.
    Antimicrob Agents Chemother; 1990 Dec; 34(12):2364-8. PubMed ID: 2088191
    [Abstract] [Full Text] [Related]

  • 8. Effect of concomitant administration of piperacillin on the dispositions of isepamicin and gentamicin in patients with end-stage renal disease.
    Halstenson CE, Wong MO, Herman CS, Heim-Duthoy KL, Teal MA, Affrime MB, Kelloway JH, Keane WF, Awni WM.
    Antimicrob Agents Chemother; 1992 Sep; 36(9):1832-6. PubMed ID: 1416875
    [Abstract] [Full Text] [Related]

  • 9. Clinical pharmacokinetics and pharmacodynamics of isepamicin.
    Tod M, Padoin C, Petitjean O.
    Clin Pharmacokinet; 2000 Mar; 38(3):205-23. PubMed ID: 10749517
    [Abstract] [Full Text] [Related]

  • 10. Disposition of cefmetazole in healthy volunteers and patients with impaired renal function.
    Halstenson CE, Guay DR, Opsahl JA, Hirata CA, Olanoff LS, Novak E, Ko H, Cathcart KS, Matzke GR.
    Antimicrob Agents Chemother; 1990 Apr; 34(4):519-23. PubMed ID: 2344159
    [Abstract] [Full Text] [Related]

  • 11. Effects of renal dysfunction on the pharmacokinetics of loracarbef.
    Therasse DG, Farlow DS, Davidson RL, Quadracci LJ, Hatcher BL, Cerimele BJ, DeSante KA.
    Clin Pharmacol Ther; 1993 Sep; 54(3):311-6. PubMed ID: 8375126
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of ceftibuten-cis and its trans metabolite in healthy volunteers and in patients with chronic renal insufficiency.
    Kelloway JS, Awni WM, Lin CC, Lim J, Affrime MB, Keane WF, Matzke GR, Halstenson CE.
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2267-74. PubMed ID: 1803999
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of cidofovir in renal insufficiency and in continuous ambulatory peritoneal dialysis or high-flux hemodialysis.
    Brody SR, Humphreys MH, Gambertoglio JG, Schoenfeld P, Cundy KC, Aweeka FT.
    Clin Pharmacol Ther; 1999 Jan; 65(1):21-8. PubMed ID: 9951427
    [Abstract] [Full Text] [Related]

  • 14. Cefonicid kinetics in subjects with normal and impaired renal function.
    Blair AD, Maxwell BM, Forland SC, Jacob L, Cutler RE.
    Clin Pharmacol Ther; 1984 Jun; 35(6):798-803. PubMed ID: 6734031
    [Abstract] [Full Text] [Related]

  • 15. Ceforanide kinetics in renal insufficiency.
    Hawkins SS, Alford RH, Stone WJ, Smyth RD, Pfeffer M.
    Clin Pharmacol Ther; 1981 Oct; 30(4):468-74. PubMed ID: 7285481
    [Abstract] [Full Text] [Related]

  • 16. Cefotaxime and desacetyl cefotaxime kinetics in renal impairment.
    Matzke GR, Abraham PA, Halstenson CE, Keane WF.
    Clin Pharmacol Ther; 1985 Jul; 38(1):31-6. PubMed ID: 4006373
    [Abstract] [Full Text] [Related]

  • 17. Disposition of minoxidil in patients with various degrees of renal function.
    Halstenson CE, Opsahl JA, Wright CE, Fleishaker JC, Andreadis NA, Sobieraj J, Matzke GR.
    J Clin Pharmacol; 1989 Sep; 29(9):798-802. PubMed ID: 2808745
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of intravenous ciprofloxacin in normal and renally impaired subjects.
    Shah A, Lettieri J, Blum R, Millikin S, Sica D, Heller AH.
    J Antimicrob Chemother; 1996 Jul; 38(1):103-16. PubMed ID: 8858462
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics of carumonam in patients with renal insufficiency.
    Horber F, Egger HJ, Weidekamm E, Dubach UC, Frey FJ, Probst PJ, Stoeckel K.
    Antimicrob Agents Chemother; 1986 Jan; 29(1):116-21. PubMed ID: 3729324
    [Abstract] [Full Text] [Related]

  • 20. Single-dose pharmacokinetics of isepamicin in young and geriatric volunteers.
    Nomeir AA, Radwanski E, Cutler D, Affrime M, Christopher D, Korduba C, Batra V, Lin CC, Cayen MN.
    J Clin Pharmacol; 1997 Nov; 37(11):1021-30. PubMed ID: 9505995
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.